ask="N/A"
ask_size="N/A"
average_daily_volume="292815"
bid="33.09"
bid_size="100"
book_value="6.19"
change="+0.71"
change_from_200_day_moving_average="2.23"
change_from_50_day_moving_average="1.53"
change_from_52_week_high="-5.95"
change_From_52_week_low="19.38"
change_in_percent="+2.20%"
close="32.97"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.06"
ebitda="-175.77M"
eps_estimate_current_year="-3.83"
eps_estimate_next_quarter="-1.03"
eps_estimate_next_year="-3.92"
ex_dividend_date="N/A"
float_shares="31720000"
high="33.05"
high_52_weeks="38.92"
last_trade_date="2/15/2017"
last_trade_price="32.97"
last_trade_size="15132"
last_trade_time="4:00pm"
low="31.79"
low_52_weeks="13.59"
market_capitalization="1.71B"
moving_average_200_day="30.74"
moving_average_50_day="31.44"
name="Theravance Biopharma
Inc."
notes="N/A"
one_year_target_price="34.71"
open="32.18"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="+7.24%"
percent_change_from_50_day_moving_average="+4.87%"
percent_change_from_52_week_high="-15.29%"
percent_change_from_52_week_low="+142.60%"
previous_close="32.26"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.21"
price_per_sales="35.77"
revenue="46.85M"
shares_outstanding="51942000"
short_ratio="19.05"
stock_exchange="NGM"
symbol="TBPH"
volume="211532"
weeks_range_52="13.59 - 38.92"
